GSK Aktie

33,80 EUR -0,60 EUR -1,74 %

09:17:18

STU

40,02 USD +0,82 USD +2,08 %

29.05.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.71,49 Mrd. EUR

KGV20,95Div. Rendite4,53%

WKNA3DMHS

ISINUS37733W2044

SymbolGSK

GSK Aktien News

Sortieren:Datum Meistgelesen

07.04.25PR NewswireGSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit with the Schall Law Firm

31.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK

28.03.25PR NewswireGSK Deadline: GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit

WerbungGSK-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

27.03.25PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK

26.03.25PR NewswireViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program

17.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK

07.03.25PR NewswireLevi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of GSK plc(GSK) Shareholders

04.03.25PR NewswireGSK plc Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK

03.03.25PR NewswireGSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit

28.02.25PR NewswireGSK plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK

26.02.25PR NewswireGSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit

25.02.25PR NewswireGSK plc. (GSK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

16.02.25PR NewswireGSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

14.02.25PR NewswireShareholders of GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK

13.02.25PR NewswireViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis

07.02.25PR NewswireGSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

06.02.25PR NewswireGSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit

31.07.24PR NewswireViiV Healthcare announces positive data demonstrating 2-drug regimen DOVATO is as effective as 3-drug regimen BIKTARVY for maintenance therapy of HIV-1

28.06.23PR NewswireStock-exchange announcement - For media and investors only - GSK completes acquisition of BELLUS Health

28.03.23PR NewswirePhase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemother...

10.02.23PR NewswireUS FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer

05.01.23PR NewswireWuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

GSK News

GSK News: auf dieser Seite finden Sie alle GSK News und Nachrichten zur GSK Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch GSK News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um GSK News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.